Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes

Cardiac natriuretic peptides (NPs) bind to two receptors (NPRA‐mediator of signaling; NPRC‐clearance receptor) whose ratio, NPRR (NPRA/NPRC), determines the NP bioactivity. This study investigated the relationship of NP receptor gene expression in adipose tissue and muscle with obesity and glucose intolerance. Prospectively, the study also assessed whether changes in NP receptor expression and thermogenic gene markers accompanied improvements of insulin sensitivity.

[1]  S. O’Rahilly,et al.  Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects , 2004, International Journal of Obesity.

[2]  F. Salvi,et al.  Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans , 2008, Journal of hypertension.

[3]  P. Dessı̀-Fulgheri,et al.  Expression of natriuretic peptide receptors in human adipose and other tissues , 1996, Journal of endocrinological investigation.

[4]  C. Mantzoros,et al.  Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. , 2010, European journal of endocrinology.

[5]  B. Spiegelman,et al.  FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. , 2012, Genes & development.

[6]  F. Crampes,et al.  Control of lipolysis by natriuretic peptides and cyclic GMP , 2008, Trends in Endocrinology & Metabolism.

[7]  L. Potter.  Natriuretic peptide metabolism, clearance and degradation , 2011, The FEBS journal.

[8]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[9]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[10]  J. Jordan,et al.  Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  Alexander S. Banks,et al.  Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch , 2014, Cell.

[12]  M. Yamauchi,et al.  The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Sweep,et al.  Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans , 2008, Diabetes.

[14]  K. Nakao,et al.  Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity , 2009, Diabetes.

[15]  R. Sarzani,et al.  The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. , 1998, Journal of nephrology.

[16]  G. Ailhaud,et al.  Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. , 2012, The Journal of clinical investigation.

[17]  S. Collins,et al.  A heart–adipose tissue connection in the regulation of energy metabolism , 2014, Nature Reviews Endocrinology.

[18]  A. Bergmann,et al.  Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? , 2012, The Journal of clinical endocrinology and metabolism.

[19]  S. Cinti.  The adipose organ at a glance , 2012, Disease Models & Mechanisms.

[20]  M. Berlan,et al.  Natriuretic peptides: a new lipolytic pathway in human adipocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  K. Pandey.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation. , 2011, Canadian journal of physiology and pharmacology.

[22]  D. Levy,et al.  Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals , 2007, Circulation.

[23]  K. Kristiansen,et al.  The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. , 2010, American journal of physiology. Endocrinology and metabolism.

[24]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.

[25]  Christoph Handschin,et al.  Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.

[26]  T. Hunter,et al.  Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation* , 2001, The Journal of Biological Chemistry.

[27]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[28]  R. Sarzani,et al.  Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[29]  K. Bailey,et al.  Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease. , 2015, Hypertension.

[30]  中辻 秀朗.  Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells , 2011 .

[31]  V. Fonseca.  Effect of thiazolidinediones on body weight in patients with diabetes mellitus. , 2003, The American journal of medicine.

[32]  J. Jordan,et al.  Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. , 2012, Journal of Clinical Investigation.

[33]  D. Dickey,et al.  Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. , 2006, Endocrine reviews.